bioXclusters’ SMEs will benefit from a Strategic entry point to South Korean Health Market through the Incheon Bio Gateway - IFEZ: Incheon Free Economic Zone

Submitted by Emilie ROMEO on 11 July 2018

July 2018

The 4 Clusters' Representatives from bioXclusters and the Incheon Bio Gateway (IFEZ) organization signed a Gateway Agreement to offer free services and guidance for SMEs in their operations in South Korea. IFEZ organization is fully dedicated to build global top Bio Hub whereby multinational companies and professionals are moving and growing. Its strategy to achieve global bio hub is extending its business area from Biopharma to such as big data healthcare, medical and AI together with setting up infrastructures to support them.

As set in the agreement, European companies of personalized medicine are eligible for IFEZ consultation package, facilitating market entry and cooperation partners identification in South Korea. Services might precisely include providing Korea Biopharma market overviews, help to make investment into Korea, introducing Korea Bio Firms (SMEs. Ventures, Corporation) collaborating with Korea Bio associations.

Learn more about IFEZ

Learn more about BioXclusters

Cluster organisation
Share this Article